Multiplex analysis of inflammatory proteins: A comparative study across multiple platforms

2 Nov 2022

In this white paper, Olink compares the Olink® Target 48 Cytokine panel head-to-head with two commonly used commercial multiplex proteomics platforms. In this comparative study, it aimed to verify the quality of the Olink technology relative to similar products widely used in protein biomarker research.

Links

Tags